These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1854464)

  • 61. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
    Byyny RL; Merrill DD; Bradstreet TE; Sweet CS
    Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
    Goa KL; Wagstaff AJ
    Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
    Duranteau J; Pussard E; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
    Ohtawa M; Takayama F; Saitoh K; Yoshinaga T; Nakashima M
    Br J Clin Pharmacol; 1993 Mar; 35(3):290-7. PubMed ID: 8471405
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects.
    Müller P; Cohen T; de Gasparo M; Sioufi A; Racine-Poon A; Howald H
    Eur J Clin Pharmacol; 1994; 47(3):231-45. PubMed ID: 7867676
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
    Christen Y; Waeber B; Nussberger J; Porchet M; Borland RM; Lee RJ; Maggon K; Shum L; Timmermans PB; Brunner HR
    Circulation; 1991 Apr; 83(4):1333-42. PubMed ID: 2013151
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
    Munafo A; Christen Y; Nussberger J; Shum LY; Borland RM; Lee RJ; Waeber B; Biollaz J; Brunner HR
    Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
    Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD
    Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dose-response relationships following oral administration of DuP 753 to normal humans.
    Christen Y; Waeber B; Nussberger J; Lee RJ; Timmermans PB; Brunner HR
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):350S-353S. PubMed ID: 1854464
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vivo pharmacology of DuP 753.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):288S-298S. PubMed ID: 1854454
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Angiotensin II antagonists DuP 753 and TCV 116.
    Brunner HR; Delacrétaz E; Nussberger J; Burnier M; Waeber B
    J Hypertens Suppl; 1994 Nov; 12(9):S29-34. PubMed ID: 7884581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical experience with angiotensin II receptor antagonists.
    Lee RJ; Brunner HR
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Angiotensin II antagonists.
    Brunner HR; Nussberger J; Burnier M; Waeber B
    Clin Exp Hypertens; 1993 Nov; 15(6):1221-38. PubMed ID: 8268887
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.